Institutional Ownership Revance Therapeutics, Inc. (RVNC)
This table provides information about the institutional ownership of Revance Therapeutics, Inc. (RVNC). We have compiled data on the 208 institutions that hold shares in the stock, with a total of 81.6 Million shares, which have been reported (via 13F filing form) to have a value of $210 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
893,686
shares
|
$2.3 Million
0.0% of portfolio
|
Q4 2024
Added 3.06%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
812,927
shares
|
$2.09 Million
0.0% of portfolio
|
Q4 2024
Reduced 30.12%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
797,299
shares
|
$2.05 Million
0.0% of portfolio
|
Q4 2024
Added 0.82%
|
|
|
Water Island Capital LLC
New York, NY |
Feb 13, 2025 Q4 2024 |
722,234
shares
|
$1.86 Million
0.25% of portfolio
|
Q4 2024
Reduced 69.67%
|
|
|
Rice Hall James & Associates, LLC
|
Jan 31, 2025 Q4 2024 |
678,541
shares
|
$1.74 Million
0.11% of portfolio
|
Q4 2024
Reduced 7.07%
|
|
|
Slotnik Capital, LLC
Dallas, TX |
Feb 12, 2025 Q4 2024 |
671,607
shares
|
$1.73 Million
0.92% of portfolio
|
Q4 2024
New holding
|
|
|
Susquehanna Fundamental Investments, LLC
Bala Cynwyd, PA |
Feb 14, 2025 Q4 2024 |
551,224
shares
|
$1.42 Million
0.02% of portfolio
|
Q4 2024
New holding
|
|
|
Fny Investment Advisers, LLC
|
Jan 13, 2025 Q4 2024 |
477,823
shares
|
$1.23 Million
0.75% of portfolio
|
Q4 2024
Added 160.39%
|
|
|
Essex Woodlands Management, Inc.
The Woodlands, TX |
Feb 13, 2025 Q4 2024 |
457,085
shares
|
$1.17 Million
0.27% of portfolio
|
Q4 2021
Reduced 3.28%
|
|
|
Man Group PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
443,544
shares
|
$1.14 Million
0.0% of portfolio
|
Q4 2024
Added 47.85%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
423,189
shares
|
$1.09 Million
0.0% of portfolio
|
Q4 2024
Reduced 7.06%
|
|
|
Hudson Bay Capital Management LP
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
414,310
shares
|
$1.06 Million
0.0% of portfolio
|
Q4 2024
Added 176.21%
|
|
|
Barclays PLC
London, X0 |
Feb 13, 2025 Q4 2024 |
402,691
shares
|
$1.03 Million
0.0% of portfolio
|
Q4 2024
Added 132.29%
|
|
|
Rothschild & CO Asset Management Us Inc.
New York, NY |
Feb 14, 2023 Q4 2022 |
369,648
shares
|
$949,995
0.1% of portfolio
|
Q4 2022
Added 71.98%
|
|
|
Vazirani Asset Management LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
350,000
shares
|
$899,500
2.97% of portfolio
|
Q4 2024
Added 250.0%
|
|
|
Lmr Partners LLP
London, X0 |
Feb 14, 2025 Q4 2024 |
347,207
shares
|
$892,321
0.01% of portfolio
|
Q4 2024
Reduced 84.53%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Feb 14, 2025 Q4 2024 |
303,073
shares
|
$778,897
0.0% of portfolio
|
Q4 2024
Added 435.17%
|
|
|
Candriam S.C.A.
|
Feb 06, 2025 Q4 2024 |
299,039
shares
|
$768,530
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Exodus Point Capital Management, LP
New York, NY |
Feb 12, 2025 Q4 2024 |
297,458
shares
|
$764,467
0.01% of portfolio
|
Q4 2024
Added 137.97%
|
|
|
New York Life Investment Management LLC
New York, NY |
Feb 04, 2025 Q4 2024 |
295,670
shares
|
$759,871
0.01% of portfolio
|
Q4 2024
Added 114.89%
|
|
|
Cubist Systematic Strategies, LLC
Stamford, CT |
Feb 14, 2025 Q4 2024 |
293,675
shares
|
$754,744
0.01% of portfolio
|
Q4 2024
Added 27.35%
|
|
|
International Biotechnology Trust PLC
London, X0 |
Nov 14, 2023 Q3 2023 |
288,726
shares
|
$742,025
1.12% of portfolio
|
Q2 2023
Added 57.77%
|
|
|
Marshall Wace, LLP
London, X0 |
Feb 13, 2025 Q4 2024 |
252,468
shares
|
$648,842
0.0% of portfolio
|
Q4 2024
Reduced 55.5%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Feb 14, 2025 Q4 2024 |
237,409
shares
|
$610,141
0.0% of portfolio
|
Q4 2024
Reduced 10.48%
|
|
|
Prelude Capital Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
202,180
shares
|
$519,602
0.03% of portfolio
|
Q4 2024
Reduced 0.5%
|